Axon Enterprise, Inc. (NASDAQ:AXON) Shares Sold by Whitaker Myers Wealth Managers LTD.

Whitaker Myers Wealth Managers LTD. decreased its position in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 59.6% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 389 shares of the biotechnology company’s stock after selling 575 shares during the quarter. Whitaker Myers Wealth Managers LTD.’s holdings in Axon Enterprise were worth $231,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently modified their holdings of AXON. Envestnet Asset Management Inc. lifted its holdings in shares of Axon Enterprise by 12.0% during the second quarter. Envestnet Asset Management Inc. now owns 79,908 shares of the biotechnology company’s stock worth $23,512,000 after purchasing an additional 8,575 shares during the period. Dimensional Fund Advisors LP lifted its holdings in shares of Axon Enterprise by 10.6% during the second quarter. Dimensional Fund Advisors LP now owns 186,473 shares of the biotechnology company’s stock worth $54,874,000 after purchasing an additional 17,905 shares during the period. Meiji Yasuda Asset Management Co Ltd. lifted its holdings in shares of Axon Enterprise by 11.2% during the second quarter. Meiji Yasuda Asset Management Co Ltd. now owns 1,112 shares of the biotechnology company’s stock worth $327,000 after purchasing an additional 112 shares during the period. Amalgamated Bank lifted its holdings in shares of Axon Enterprise by 0.5% during the second quarter. Amalgamated Bank now owns 15,347 shares of the biotechnology company’s stock worth $4,516,000 after purchasing an additional 71 shares during the period. Finally, Vanguard Personalized Indexing Management LLC lifted its holdings in shares of Axon Enterprise by 7.8% during the second quarter. Vanguard Personalized Indexing Management LLC now owns 6,354 shares of the biotechnology company’s stock worth $1,843,000 after purchasing an additional 462 shares during the period. Institutional investors and hedge funds own 79.08% of the company’s stock.

Axon Enterprise Stock Up 1.4 %

Shares of AXON opened at $593.89 on Friday. The company has a debt-to-equity ratio of 0.32, a quick ratio of 2.63 and a current ratio of 2.96. Axon Enterprise, Inc. has a one year low of $247.04 and a one year high of $698.67. The stock has a market capitalization of $45.28 billion, a price-to-earnings ratio of 153.46, a PEG ratio of 5.71 and a beta of 1.04. The stock has a 50 day moving average price of $617.37 and a 200 day moving average price of $459.99.

Analyst Ratings Changes

A number of research analysts have issued reports on AXON shares. Robert W. Baird boosted their price target on Axon Enterprise from $600.00 to $800.00 and gave the company an “outperform” rating in a report on Friday, December 6th. Northland Securities boosted their price target on Axon Enterprise from $365.00 to $550.00 and gave the company an “outperform” rating in a report on Monday, November 11th. Needham & Company LLC boosted their price target on Axon Enterprise from $525.00 to $600.00 and gave the company a “buy” rating in a report on Friday, November 8th. JMP Securities boosted their price target on Axon Enterprise from $430.00 to $500.00 and gave the company a “market outperform” rating in a report on Thursday, October 31st. Finally, Morgan Stanley raised Axon Enterprise from an “equal weight” rating to an “overweight” rating and boosted their price target for the company from $500.00 to $700.00 in a report on Tuesday, December 3rd. One equities research analyst has rated the stock with a hold rating and fourteen have given a buy rating to the company. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $504.92.

Insider Buying and Selling

In other Axon Enterprise news, Director Caitlin Elizabeth Kalinowski sold 450 shares of the company’s stock in a transaction on Thursday, January 2nd. The stock was sold at an average price of $604.07, for a total value of $271,831.50. Following the completion of the sale, the director now directly owns 6,929 shares in the company, valued at $4,185,601.03. This represents a 6.10 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, President Joshua Isner sold 20,000 shares of the company’s stock in a transaction on Tuesday, November 12th. The shares were sold at an average price of $606.15, for a total value of $12,123,000.00. Following the completion of the sale, the president now owns 208,166 shares of the company’s stock, valued at approximately $126,179,820.90. The trade was a 8.77 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 50,545 shares of company stock worth $30,721,337. 5.70% of the stock is owned by corporate insiders.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.